Biomimetic nanofiber tissue scaffolds

Abstract

A biomimetic tissue scaffold for repairing an elongated tissue in need of repair can comprise a plurality of coiled flexible polymeric ribbons having a surface on which is formed an array of nanofibers, the ribbons forming a tubular body defining a first open end in which a first end of the elongated tissue is receivable, a second open end in which a second end of the elongated tissue is receivable, and a lumen extending between the first and second open ends.

Description

[0001]A portion of the disclosure of this patent document contains material that is subject to copyright protection. The copyright owner has no objection to the reproduction of the patent document or the patent disclosure, as it appears in the U.S. Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.CROSS-REFERENCES TO RELATED APPLICATIONS[0002]Not Applicable.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0003]Not Applicable.REFERENCE TO SEQUENCE LISTING OR COMPUTER PROGRAM LISTING APPENDIX[0004]Not Applicable.BACKGROUND OF THE INVENTION[0005]Stem Cells and the Extracellular Matrix[0006]The use of stem cells for regenerative treatment of injuries is now commonplace. Stem cells from bone marrow aspirate or other sources are frequently injected into knees as a treatment for arthritis. Embryonic stem cells derived from umbilical cord blood and tissue are introduced intravenously in an attempt to cure various chroni...

AI Technical Summary

Benefits of technology

The present invention provides scaffolds that mimic the natural structure of collagen tendrils, which are important components of the extracollagenous matrix. These scaffolds have arrays of nanofibers that are organized like the tendrils and are attached to a stiffer matrix of cross-linked fibers. The nanofibers are tapered with decreasing stiffness along their length, which allows for secure attachment of cells and also induces shear stresses between the scaffold and cells. The scaffolds may also be used for tissue augmentation by providing optimal physical properties and favorable nanofiber arrays that affect tissue differentiation and propagation.

Problems solved by technology

While these treatments may be beneficial for some conditions, their regenerative abilities are limited because they lack a physiologically structured extracellular matrix (“ECM”).

It is not an environmentally friendly process due to the solvents required.

When forming nanofibers by electrospinning, the nanofiber materials are limited to polymers that can be mixed with a solvent to achieve the properties required for the process.

If there is retained solvent in the nanofibers, the behavior of cells within a scaffold formed therefrom may be adversely affected.

While the nanofibers of the previously described prior art examples are of a scale similar to fibrous tissue forming the ECM, they do not provide a biomimetic structure.

However, it must be noted that the fiber length in these “tuned” fibrous scaffolds is not controlled and therefore cannot be optimized for a given use.

Indeed, the average density and effective pore size can only be controlled within broad ranges.

Advantages that may be achieved through control of the length, orientation, and three-dimensional arrangement of fibers cannot be realized with current commonly used manufacturing techniques.

Naturally occurring structures within the body are not limited in the way that these manufactured scaffolds are limited.

Accordingly, while the manufactured scaffolds may be referred to as “biomimetic” in that they grossly mimic natural structures, their long continuous fibers, regardless of orientation, do not provide sites for cell attachment that mimic the tendrils of the ECM, and the focal attachments of the tendrils with their inherent ability to provide outside-in signaling to the cell, thereby affecting cell behavior.

Images